Related Experiment Video
Updated: Jul 20, 2025
10:02
piggyBac Transposon System Modification of Primary Human T Cells
Published on: November 5, 2012
17.4K
Quantum pBac: An effective, high-capacity piggyBac-based gene integration vector system for unlocking gene therapy
Wei-Kai Hua1, Jeff C Hsu1, Yi-Chun Chen1
1GenomeFrontier Therapeutics, Inc, New Taipei City, Taiwan ROC.
Summary
A novel virus-free gene therapy vector, Quantum pBac™ (qPB), enhances CAR-T cell production for cancer treatment. This system offers improved efficiency, yield, and safety compared to existing methods, advancing therapeutic potential.
Area of Science:
- Biotechnology
- Gene Therapy
- Immunotherapy
Background:
- Viral vectors limit gene therapy's potential due to payload capacity.
- DNA transposons offer a virus-free alternative for gene delivery.
- Previous piggyBac systems show promise but require optimization.
Purpose of the Study:
- To improve the piggyBac system for enhanced gene therapy applications.
- To develop an optimal piggyBac system (Quantum pBac™ or qPB) for T cell modification.
- To evaluate qPB's efficiency and safety in CAR-T cell production.
Main Methods:
- Engineered a hyperactive piggyBac (hyPB) system by identifying enhancer elements (IDS).
- Developed a plasmid-free donor vector and utilized Quantum PBase™ v2.
- Compared qPB with hyPB and lentiviral vectors for CAR-T cell production.
Main Results:
- The optimized qPB system demonstrated superior transposition efficiency and CAR-T cell yield.
- qPB produced CAR-T cells with lower variability than lentiviral vectors.
- qPB-generated CAR-T cells effectively eliminated tumor cells in vitro and in vivo.
Conclusions:
- Quantum pBac™ (qPB) is a highly efficient, virus-free gene delivery system.
- qPB exhibits enhanced payload capacity for multiple gene integration.
- This system holds significant promise for advancing cancer gene therapy and other applications.
